A Systematic Review of the Screening Accuracy of the HIV Dementia Scale and International HIV Dementia Scale

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Haddow, Lewis John ^a   Floyd, Sian ^b   Copas, Andrew ^a   Gilson, Richard John Cary ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; CLINICAL ASSESSMENT; COGNITIVE DEFECT; DEMENTIA; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; GOLD STANDARD; HIV ASSOCIATED DEMENTIA; HIV DEMENTIA SCALE; HUMAN; INTERNATIONAL HIV DEMENTIA SCALE; NORTH AMERICA; RATING SCALE; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

AIDS DEMENTIA COMPLEX; HUMANS; NEUROPSYCHOLOGICAL TESTS;

EID: 84876184548     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061826     Document Type: Review

References (86)

1. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, et al. (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69: 1789-1799.
2. Simioni S, Cavassini M, Annoni JM, Rimbault Abraham A, Bourquin I, et al. (2010) Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 24: 1243-1250.
3. Heaton RK, Clifford DB, Franklin DRJ, Woods SP, Ake C, et al. (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75: 2087-2096.
4. Reiss P, Battegay M, Clumeck N, Mulcahy F, Arribas J,et al. (2011) European AIDS Clinical Society Guidelines. Paris, France.
5. Williams IG, Churchill D, Anderson J, Boffito M, Bower M, et al. (2012) British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy. HIV Medicine 13: 1-85.
6. Gisslen M, Price RW, Nilsson S, (2011) The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence? BMC Infectious Diseases 11: 356.
7. American Academy of Neurology AIDS Task Force, (1991) Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group. Neurology 41: 778-785.
8. Price RW, Brew BJ, (1988) The AIDS dementia complex. Journal of Infectious Diseases 158: 1079-1083.
9. Power C, Selnes OA, Grim JA, McArthur JC, (1995) HIV Dementia Scale: a rapid screening test. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 8: 273-278.
10. Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, et al. (2005) The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS 19: 1367-1374.
11. Davis HF, Skolasky RL, Selnes OA, Burgess DM, McArthur JC, (2002) Assessing HIV-associated dementia: modified HIV dementia scale versus the Grooved Pegboard. AIDS Reader 12: 29-31.
12. Kvalsund MP, Haworth A, Murman DL, Velie E, Birbeck GL, (2009) Closing gaps in antiretroviral therapy access: human immunodeficiency virus-associated dementia screening instruments for non-physician healthcare workers. American Journal of Tropical Medicine and Hygiene 80: 1054-1059.
13. Skinner S, Adewale AJ, DeBlock L, Gill MJ, Power C, (2009) Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy. HIV Medicine 10: 246-252.
14. Lyon ME, McCarter R, D'Angelo LJ, (2009) Detecting HIV associated neurocognitive disorders in adolescents: what is the best screening tool? Journal of Adolescent Health 44: 133-135.
15. Jones BN, Teng EL, Folstein MF, Harrison KS, (1993) A new bedside test of cognition for patients with HIV infection. Annals of Internal Medicine 119: 1001-1004.
16. Minor KS, Jones GN, Stewart DW, Hill BD, Kulesza M, (2010) Comparing two measures of psychomotor performance in patients with HIV: the Coin Rotation Test and the Modified HIV Dementia Screen. Journal of Acquired Immune Deficiency Syndromes 55: 225-227.
17. Chan LG, Kandiah N, Chua A, (2012) HIV-associated neurocognitive disorders (HAND) in a South Asian population-contextual application of the 2007 criteria. BMJ Open 2: e000662.
18. Garvey LJ, Yerrakalva D, Winston A, (2009) Correlations between computerized battery testing and a memory questionnaire for identification of neurocognitive impairment in HIV type 1-infected subjects on stable antiretroviral therapy. AIDS Research & Human Retroviruses 25: 765-769.
19. Valcour VG, Paul R, Chiao S, Wendelken LA, Miller B, (2011) Screening for cognitive impairment in human immunodeficiency virus. Clinical Infectious Diseases 53: 836-842.
20. Maruff P, Thomas E, Cysique LA, Brew BJ, Collie A, et al. (2009) Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex. Archives of Clinical Neuropsychology 24: 165-178.
21. Gibbie T, Mijch A, Ellen S, Hoy J, Hutchison C, et al. (2006) Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up. HIV Medicine 7: 112-121.
22. Gonzalez R, Heaton RK, Moore DJ, Letendre S, Ellis RJ, et al. (2003) Computerized reaction time battery versus a traditional neuropsychological battery: detecting HIV-related impairments. Journal of the International Neuropsychological Society 9: 64-71.
23. Morgan EE, Woods SP, Scott JC, Childers M, Beck JM, et al. (2008) Predictive validity of demographically adjusted normative standards for the HIV Dementia Scale. Journal of Clinical and Experimental Neuropsychology 30: 83-90.
24. Wojna V, Skolasky RL, McArthur JC, Maldonado E, Hechavarria R, et al. (2007) Spanish validation of the HIV dementia scale in women. AIDS Patient Care STDS 21: 930-941.
25. Joska JA, Westgarth-Taylor J, Hoare J, Thomas KGF, Paul R, et al. (2011) Validity of the International HIV Dementia Scale in South Africa. AIDS Patient Care STDS 25: 95-101.
26. Valcour VG, Shiramizu BT, Sithinamsuwan P, Nidhinandana S, Ratto-Kim S, et al. (2009) HIV DNA and cognition in a Thai longitudinal HAART initiation cohort: the SEARCH 001 Cohort Study. Neurology 21: 992-998.
27. Waldrop-Valverde D, Nehra R, Sharma S, Malik A, Jones D, et al. (2010) Education effects on the International HIV Dementia Scale. Journal of Neurovirology 16: 264-267.
28. Garvey LJ, Surendrakumar V, Winston A, (2011) Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy. HIV Clinical Trials 12: 333-338.
29. Waters L, Patterson B, Scourfield A, Hughes A, de Silva S, et al. (2012) A dedicated clinic for HIV-positive individuals over 50 years of age: a multidisciplinary experience. International Journal of STD and AIDS 23: 546-552.
30. Roundtable Discussion (2011) Presentation of guidelines for treatment of HIV infection of the CNS in different countries. Fourth International Meeting on HIV Infection and the Central Nervous System. Monte Porzio Catone, Rome, Italy.
31. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, et al. (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. British Medical Journal 326: 41-44.
32. Cherner M, Cysique LA, Heaton RK, Marcotte TD, Ellis RJ, et al. (2007) Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders. Journal of Neurovirology 13: 23-28.
33. Gandhi NS, Moxley RT, Creighton J, Vornbrock Roosa H, Skolasky RL, et al. (2010) Comparison of scales to evaluate the progression of HIV-associated neurocognitive disorder. HIV Therapy 4: 371-379.
34. Jaeschke R, Guyatt GH, Sackett DL, (1994) Users' guides to the medical literature. VI. How to use an article about a diagnostic test. B: What are the results and will they help me in caring for my patients? Journal of the American Medical Association 271: 703-707.
35. Deeks JJ (2001) Systematic reviews of evaluations of diagnostic and screening tests. In: Egger M, Davey Smith G, Altman D, editors. Systematic Reviews in Health Care: Meta-analysis in Context.London, UK: BMJ Publishing Group. pp. 248-284.
36. Midgette AS, Stukel TA, Littenberge B, (1993) A meta-analytical method for summarizing diagnostic test performance: receiver-operating characteristic-curve point estimates. Medical Decision Making 13: 253-257.
37. Moses LE, Shapiro D, Littenberg B, (1993) Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Statistics in Medicine 12: 1293-1316.
38. Andres MA, Feger U, Nath A, Munsaka S, Jiang CS, et al. (2011) APOE ε4 allele and CSF APOE on Cognition in HIV-Infected Subjects. Journal of Neuroimmune Pharmacology 6: 389-398.
39. Arendt G, Koutsilieri E, Sopper S, Husstedt IW, Maschke M,et al. (2009) The influence of cytokines on neuropsychological performance in HIV patients. 12th European AIDS Conference. Cologne, Germany.
40. Chang L, Wong V, Nakama H, Watters M, Ramones D, et al. (2008) Greater than age-related changes in brain diffusion of HIV patients after 1 year. J Neuroimmune Pharmacol 3: 265-274.
41. Chang L, Ernst T, Leonido-Yee M, Speck O, (2000) Perfusion MRI detects rCBF abnormalities in early stages of HIV-cognitive motor complex. Neurology 54: 389-396.
42. Dougherty RH, Skolasky RL, McArthur JC, (2002) Progression of HIV-associated dementia treated with HAART. AIDS Reader 12: 69-74.
43. Ernst T, Chang L, Arnold S, (2003) Increased glial metabolites predict increased working memory network activation in HIV brain injury. Neuroimage 19: 1686-1693.
44. Kim DH, Jewison DL, Milner GR, Rourke SB, Gill MJ, et al. (2001) Neurocognitive symptoms and impairment in an HIV community clinic. Canadian Journal of Neurological Science 28: 228-231.
45. Guillemi S, Gil D, Hull M, Harris M, Hsiung R,et al. (2011) Results of CSF viral load in HIV-positive patients on stable antiretroviral therapy (ART) attending a neurocognitive disorder clinic (NDC). 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Rome, Italy.
46. Pessin H, Rosenfeld B, Burton L, Breitbart W, (2003) The role of cognitive impairment in desire for hastened death: a study of patients with advanced AIDS. General Hospital Psychiatry 25: 194-199.
47. von Giesen HJ, Köller H, de Nocker D, Haslinger BA, Arendt G, (2003) Long-term safety and efficacy of NNRTI within the central nervous system. HIV Clinical Trials 4: 382-390.
48. Wang GJ, Chang L, Volkow ND, Telang F, Logan J, et al. (2004) Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain 127: 2452-2458.
49. Ashby J, Foster CJ, Garvey LJ, Wan T, Allsop JM,et al. (2011) Cerebral function in perinatally HIV-infected young adults and their HIV-uninfected sibling controls. 17th Annual Conference of the British HIV Association. Bournemouth, UK.
50. Birbeck GL, Kvalsund MP, Byers PA, Bradbury R, Mang'ombe C, et al. (2011) Neuropsychiatric and socioeconomic status impact antiretroviral adherence and mortality in rural Zambia. American Journal of Tropical Medicine and Hygiene 85: 782-789.
51. Choi Y, Townend J, Vincent T, Zaidi I, Sarge-Njie R, et al. (2011) Neurologic manifestations of human immunodeficiency virus-2: dementia, myelopathy, and neuropathy in West Africa. Journal of Neurovirology 17: 166-175.
52. Clifford DB, Mitike MT, Mekonnen Y, Zhang J, Zenebe G, et al. (2007) Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia. Journal of Neurovirology 13: 67-72.
53. Gasnault J, Dulioust A, Sellier P, Dolphin P, Paquet C (2010) COGNIVIH, une échelle brève de dépistage des troubles neurocognitifs chez les personnes vivant avec le VIH: données préliminaires. 3e Forum de Recherches Fondamentales et Cliniques sur le VIH. Paris, France.
54. Holguin A, Banda M, Willen EJ, Malama C, Chiyenu KO, et al. (2011) HIV-1 effects on neuropsychological performance in a resource-limited country, Zambia. AIDS and Behavior 15: 1895-1901.
55. Lawler K, Mosepele M, Ratcliffe S, Seliolwe E, Steele K, et al. (2010) Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study. Journal of the International AIDS Society 13: 15.
56. Pumpradit W, Ananworanich J, Lolak S, Shikuma C, Paul R, et al. (2010) Neurocognitive impairment and psychiatric comorbidity in well-controlled human immunodeficiency virus-infected Thais from the 2NN Cohort Study. Journal of Neurovirology 16: 76-82.
57. Royal W, Cherner M, Carr J, Habib A, Akomolafe A, et al. (2012) Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria. Journal of Neurovirology 18: 191-199.
58. Sacktor N, Nakasujja N, Skolasky R, Robertson K, Wong M, et al. (2006) Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology 67: 311-314.
59. Zhang Y, Qiao L, Ding W, Wei F, Zhao Q, et al. (2012) An initial screening for HIV-associated neurocognitive disorders of HIV-1 infected patients in China. Journal of Neurovirology 18: 120-126.
60. Oshinaike OO, Akinbami AA, Ojo OO, Ojini IF, Okubadejo UN, et al. (2012) Comparison of the Minimental State Examination Scale and the International HIV Dementia Scale in Assessing Cognitive Function in Nigerian HIV Patients on Antiretroviral Therapy. AIDS Research and Treatment 2012: 581531.
61. Nakasujja N, Miyahara S, Evans S, Lee A, Musisi S, et al. (2013) Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment. Neurology 80: 196-202.
62. Perez-Valero I, Heaton RK, Letendre SL, McCutchan JA, Clifford D,et al. (2012) Validation of the EACS guidelines 2011 algorithm for detecting HAND in the CHARTER cohort. 19th Conference on Retroviruses and Opportunistic Infections. Seattle, USA. Abstract 508.
63. Avison MJ, Nath A, Greene-Avison R, Schmitt FA, Bales RA, et al. (2004) Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia. Journal of Neurovirology 10: 223-232.
64. Berghuis JP, Uldall KK, Lalonde B, (1999) Validity of two scales in identifying HIV-associated dementia. Journal of Acquired Immune Deficiency Syndromes 21: 134-140.
65. Bottiggi KA, Chang JJ, Schmitt FA, Avison MJ, Mootoor Y, et al. (2007) The HIV Dementia Scale: Predictive power in mild dementia and HAART. Journal of the Neurological Sciences 260: 11-15.
66. Carey CL, Woods SP, Rippeth JD, Gonzalez R, Moore DJ, et al. (2004) Initial validation of a screening battery for the detection of HIV-associated cognitive impairment. Clinical Neuropsychology 18: 234-248.
67. Cloak CC, Chang L, Ernst T, (2004) Increased frontal white matter diffusion is associated with glial metabolites and psychomotor slowing in HIV. Journal of Neuroimmunology 157: 147-152.
68. Ganasen KA, Fincham D, Smit J, Seedat S, Stein D, (2008) Utility of the HIV Dementia Scale (HDS) in identifying HIV dementia in a South African sample. Journal of Neurological Sciences 269: 62-64.
69. Gongvatana A, Woods SP, Taylor MJ, Vigil O, Grant I, (2007) Semantic clustering inefficiency in HIV-associated dementia. Journal of Neuropsychiatry and Clinical Neuroscience 19: 36-42.
70. Hardy DJ, Hinkin CH, Levine AJ, Castellon SA, Lam MN, (2006) Risky decision making assessed with the gambling task in adults with HIV. Neuropsychology 20: 355-360.
71. Richardson MA, Morgan EE, Vielhauer MJ, Cuevas CA, Buondonno LM, et al. (2005) Utility of the HIV dementia scale in assessing risk for significant HIV-related cognitive-motor deficits in a high-risk urban adult sample. AIDS Care 17: 1013-1021.
72. Smith CA, van Gorp WG, Ryan ER, Ferrando SJ, Rabkin J, (2003) Screening subtle HIV-related cognitive dysfunction: the clinical utility of the HIV Dementia Scale. Journal of Acquired Immune Deficiency Syndromes 33: 116-118.
73. Sakamoto M, Marcotte TD, Umlauf A, Franklin DRJ, Heaton RK, et al. (2013) Concurrent classification accuracy of the HIV Dementia Scale for HIV-Associated Neurocognitive Disorders in the CHARTER cohort. Journal of Acquired Immune Deficiency Syndromes 62: 36-42.
74. Kwasa J, Cettomai D, Lwanya E, Osiemo D, Oyaro P, et al. (2012) Lessons learned developing a diagnostic tool for HIV-associated dementia feasible to implement in resource-limited settings: pilot testing in Kenya. PLoS One 7: e32898.
75. Meyer AC, Cettomai D, Kwasa J, Oyaro P, Osiemo D,et al. (2011) Diagnostic tools and culturally-specific norms for the diagnosis of HIV-associated cognitive impairment in western Kenya. 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Rome, Italy.
76. Nakasujja N, Skolasky RL, Musisi S, Allebeck P, Robertson KR, et al. (2010) Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda. BMC Psychiatry 10: 44.
77. Sacktor N, Miyahara S, Deng L, Evans S, Schiffito G, et al. (2011) Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial. Neurology 77: 1135-1142.
78. Singh D, Goodkin K (2011) Diagnostic utility of the International HIV Dementia Scale for asymptomatic HIV-associated neurocognitive impairment and HIV-Associated Neurocognitive Disorder in South Africa. [unpublished article].
79. Singh D, Sunpath H, John S, Eastham L, Gouden R, (2008) The utility of a rapid screening tool for depression and HIV dementia amongst patients with low CD4 counts-a preliminary report. African Journal of Psychiatry 11: 282-286.
80. Muniyandi K, Venkatesan J, Arutselvi T, Jayaseelan V, (2012) Study to assess the prevalence, nature and extent of cognitive impairment in people living with AIDS. Indian Journal of Psychiatry 54: 149-153.
81. Antinori A, Balestra P, Lorenzini P, Libertone R, Cataldo G, et al. (2012) Comparison of screening tools for the detection of neurocognitive impairment in HAART-treated patients. Journal of the International AIDS Society 15: 18286.
82. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, et al. (1999) Empirical evidence of design-related bias in studies of diagnostic tests. Journal of the American Medical Association 282: 1061-1066.
83. Letendre SL, Grant I (2012) Assessment, diagnosis and treatment of Human Immunodeficiency Virus (HIV)-Associated Neurocognitive Disorders (HAND): a consensus report of the Mind Exchange program. Clinical Infectious Diseases Nov 21: [Epub ahead of print].
84. High KP, Brennan-Ing M, Clifford DB, Cohen MH, Currier J, et al. (2012) HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. Journal of Acquired Immune Deficiency Syndromes 60: 1-18.
85. Valcour V, Shikuma C, Shiramizu B, Watters M, Poff P, et al. (2004) Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Neurology 63: 822-827.
86. Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, et al. (2004) Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. Journal of Clinical and Experimental Neuropsychology 26: 759-778.